Global Animal Vaccine Market Report and Forecast 2024-2032

Global Animal Vaccine Market Outlook

The global animal vaccine market size reached a value of around USD 11.24 billion in 2023, driven by new technological advances and emergence of new diseases/virus. The market is further expected to grow at a CAGR of 7% during the forecast period of 2024-2032, likely to attain a value of around USD 20.66 billion by 2032.

Animal Vaccine: Introduction

Animal vaccine or veterinary vaccines   are given to animals to increase their life, prevent development or transmission of diseases. Vaccines are used to develop immunity of the animal against viral, bacterial, protozoal and other infections. Non-pathogenic components that can induce an immune response are present in the vaccine to develop acquired immunity in the animals. Vaccination can prevent the development of infectious disease upon exposure of the animal to the infection due to the presence of existing antibodies.

Key Trends in the Global Animal Vaccine Market

The growth of the market is primarily being driven by the rising technological advances, emergence of new diseases and development of drug resistance by pathogens  . Technological advances in biotechnology field is leading to the development of DNA Vaccines, Vectored Vaccines, Subunit Vaccines and Recombinant Vaccines for broader safety, disease coverage and improved efficacy of the vaccine against the disease. Vaccines prevent the occurrence of infectious diseases and reduces the reliance of treating the disease on antibiotics that leads to development of drug resistant bacteria. During the emergence of new disease, vaccines can play an important role in preventing and curbing the transmission of disease by vaccinating the susceptible animals in the disease prone areas.

Global Animal Vaccine Market Analysis

Based on segments, the market is divided into animal type, technology, diseases, route of administration, and region.

Market Breakup by Animal Type

• Livestock 

• Swine 

• Poultry 

• Companion Animals 

• Others

Market Breakup by Technology

• Inactive Vaccine 

• Live Attenuated Vaccine 

• Toxoid Vaccine 

• Recombinant Vaccine  

• Others

Market Breakup by Diseases

• Foot and Mouth Diseases 

• New Castle Disease 

• Infectious Bronchitis 

• Infectious Bursal Diseases

• Fowl Pox 

• Rabies 

• Others

Animal Vaccine Market Breakup by Route of Administration

• Subcutaneous 

• Intramuscular 

• Intraocular 

• Oral 

• Others

Market Breakup by Distribution Channels

• Veterinary Hospitals 

• Veterinary Clinics 

• Pharmacies 

• Others

Market Breakup by Region

• North America 

• Europe 

• Asia Pacific 

• Latin America 

• Middle East and Africa

Global Animal Vaccine Market Scenario

The growth of the market is driven by the need of preventing and controlling the diseases in livestock animals. Heathy animals are directly equivalent to more mating possibilities, a greater number of births and eventually more animal produced food. Food sourced from animals, like eggs, milk, and meat, are the sources of high-quality protein, required for development of body which are also attributing the growth of the market.

Rising awareness about the importance of animal vaccination, along with various campaigns done by the government and NGOs have contributed to the increased awareness about the importance of these vaccines. The rising awareness among farmers about keeping their animals disease and virus free by getting them vaccinated timely can help them have better output and reduce the risk of transmission of infection among their animals.

Animal Vaccine Market Competitive Landscape

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model, along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global animal vaccine market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

• Zoetis, Inc. 

• Boehringer Ingelheim International GmbH 

• Elanco Animal Health Incorporated 

• Merck & Co., Inc. 

• Ceva Sante Animale SA 

• Bayer AG 

• Virbac SA 

• Neogen Corporation 

• ImmuCell Corporation 

• Covetrus, Inc.

Key Highlights of the Report